Chr. Olesen and Co. A/S Revenue and Competitors
Estimated Revenue & Valuation
- Chr. Olesen and Co. A/S's estimated annual revenue is currently $30.4M per year.
- Chr. Olesen and Co. A/S's estimated revenue per employee is $201,000
Employee Data
- Chr. Olesen and Co. A/S has 151 Employees.
- Chr. Olesen and Co. A/S grew their employee count by 26% last year.
Chr. Olesen and Co. A/S Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $120M | 597 | 25% | N/A | N/A |
#6 | $52.9M | 263 | 13% | N/A | N/A |
#7 | $24.7M | 123 | 13% | N/A | N/A |
#8 | $1.8M | 18 | 0% | $114.3M | N/A |
#9 | $7.2M | 36 | -20% | N/A | N/A |
#10 | $13.7M | 68 | -7% | N/A | N/A |
What Is Chr. Olesen and Co. A/S?
Chr. Olesen is a distribution company. We strive to be perceived as the best link between manufactures and customers in distributing high-quality ingredients to the feed, food and pharmaceutical industries all over the world. Reliability is the quality assurance of everything we do.
keywords:N/A
N/A
Total Funding
151
Number of Employees
$30.4M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chr. Olesen and Co. A/S News
Desde 1º de Janeiro de 2022 a cadeia da produção de proteína animal no Brasil e América Latina conta com uma nova empresa, a NHU/Chr. Olesen...
New Market Report on Denmark Vermouth Market, Estimating for Years 2019-2026, and Prominent Players are, Carlsberg Group Chr. Olesen ...
The global portable medical devices market which was represented a CAGR of approximately +9% in the midst of the estimate time span of ...
... of Spepharm B.V., Bionpharma Inc., CoreRx, Inc., Leon Nanodrugs GmbH, Pharmaceutics International, Inc. and Chr. Olesen Synthesis A/S
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $48.2M | 151 | 6% | N/A |
#2 | $33.3M | 151 | -21% | $160.4M |
#3 | $34.1M | 151 | 8% | N/A |
#4 | $33.9M | 151 | N/A | N/A |
#5 | $24.1M | 151 | N/A | N/A |